Resultados de Concursos anteriores

Resultados do Concurso

Resultados do concurso Health Research 2021

HEALTH RESEARCH 2021 CALL FOR PROPOSALS - INFORMATION
HR21 Budget	22.115.490,50 €
Number of projects presented	644
Number of projects evaluated	644
Number of projects preselected	70
Number of projects selected	30
Success rate	4,66%

Table: General information of Health Research 2021 Call for Proposals.

Resultados do concurso Health Research 2020

HEALTH RESEARCH 2020 CALL FOR PROPOSALS - INFORMATION
HR20 Budget	15.200.128 €
Number of projects presented	602
Number of projects evaluated	600
Number of projects preselected	62
Number of projects selected	21
Success rate	3,50%

Table: General information of Health Research 2020 Call for Proposals.

Resultados do concurso Health Research 2019

HEALTH RESEARCH 2019 CALL FOR PROPOSALS - INFORMATION
HR18 Budget	15.376.337 €
Number of projects presented	632
Number of projects evaluated	629
Number of projects preselected	75
Number of projects selected	22
Success rate	3,50%

Table: General information of Health Research 2019 Call for Proposals.

Resultados do concurso Health Research 2018

HEALTH RESEARCH 2018 CALL FOR PROPOSALS - INFORMATION
HR17 Budget	12.000.000 €
Number of projects presented	785
Number of projects evaluated	785
Number of projects preselected	77
Number of projects selected	20

Table: General information of Health Research 2018 Call for Proposals.

Projetos selecionados

Projetos selecionados Health Research 2021

CODE	PROJECT TITLE	PROJECT LEADER	HOST ORGANIZATION	PARTNER ORGANIZATIONS	THEMATIC AREA	CATEGORY	BUDGET (€)
HR21-00046	Decoding the paracrine control of metabolic fitness by endothelial nutrient signaling	Alejo Efeyan	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	Cardiovascular and associated metabolic diseases	Research Consortium	992.580,60
HR21-00386	High precision cardioprotective therapy: a photoswitchable approach to reduce the extension of myocardial infarction	Amadeu Llebaria	Consejo Superior de Investigaciones Científicas (CSIC)	Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) - Purdue University, West Lafayette, IN - GICOR	Cardiovascular and associated metabolic diseases	Research Consortium	999.779,50
HR21-00430	Phospholipid biosynthesis and transport between endoplasmic reticulum and mitochondria: understanding their essential role in liver disorders	Antonio Zorzano	Fundació Institut de Recerca Biomèdica (IRB Barcelona)	Universitat de Barcelona - Fundació Institut d'Investigació Sanitària Pere Virgili	Cardiovascular and associated metabolic diseases	Research Consortium	997.014
HR21-00233	Loss of Triadin impairs cardiac proteostasis disclosing pathophysiological complexity in Catecholaminergic Polymorphic Ventricular Tachycardia Type 5	Silvia Giuliana Priori	Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC	N/A	Cardiovascular and associated metabolic diseases	Individual	496.100
HR21-00793	RIPK3 biology and targeting in metabolic liver disease	Cecilia Rodrigues	FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento	N/A	Cardiovascular and associated metabolic diseases	Individual	320.000,07
HR21-00375	Massively parallel mutagenesis to understand, predict and prevent amyloid nucleation in neurodegenerative diseases	Ben Lehner	Centre de Regulació Genòmica (CRG)	Institut de Bioenginyeria de Catalunya	Enabling technologies	Research Consortium	994.048,90
HR21-00925	Development of enabling technologies for T-cell immunotherapy of solid tumors	Sonia Guedán	Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	Asociación Centro de Investigación Cooperativa en Biociencias (CIC bioGUNE) - Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)	Enabling technologies	Research Consortium	963.488
HR21-00410	Graphene aptasensor bioelectronics: a neural interface for neurotransmission probing in neurological disorders	Pedro Alpuim	Laboratorio Iberico Internacional de Nanotecnologia	Universidade do Minho - Consejo Superior de Investigaciones Científicas (CSIC)	Enabling technologies	Research Consortium	997.692,19
HR21-00208	Enzyme propelled nanobots as efficient nanotech platform for bladder cancer therapy	Samuel Sánchez	Institut de Bioenginyeria de Catalunya	Asociación Centro de Investigación Cooperativa en Biomateriales - Universitat Autònoma de Barcelona (UAB) - Fundació Clínic per a la Recerca Biomèdica -Fundacio Catalunya-La Pedrera Fundacio Especial - Universitat de Barcelona - Fundació Bosch i Gimpera	Enabling Technologies	Research Consortium	997.946,50
HR21-00415	A multidisciplinary approach to understand host and pathogen interactions to develop new strategies to target tuberculosis	Margarida Saraiva	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação	Consejo Superior de Investigaciones Científicas (CSIC) - Francis Crick Institute	Infectious diseases	Research Consortium	998.404
HR21-00848	Whole-organism vaccines against P. falciparum and P. vivax malaria with enhanced efficacy and scope	Miguel Prudêncio	Instituto de Medicina Molecular	Leiden University Medical Centre - US Naval Medical Research Unit 6	Infectious diseases	Research Consortium	997.453,50
HR21-01020	Neuron-astrocyte signaling in depression: learning from astrocytes how to effectively treat depression	João Filipe Oliveira	Universidade do Minho	N/A	Neuroscience	Individual	499.478,45
HR21-00171	Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria	Hernando A. del Portillo	Institut de Salut Global de Barcelona (ISGlobal)	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação - Universitat de Barcelona - Mahidol University	Infectious diseases	Research Consortium	996.930,57
HR21-00368	Molecular dissection of TNF-mediated pathogenic macrophage necrosis in tuberculosis	Francisco Jose Roca Soler	Universidad de Murcia	N/A	Infectious diseases	Individual	460.252,80
HR21-00737	Acquisition of antifungal resistance in pathogenic Candida spp.: evolutionary paths, fitness trade-offs, and interplay with the immune system	Toni Gabaldón	Fundació Institut de Recerca Biomèdica (IRB Barcelona)	N/A	Infectious diseases	Individual	499.244
HR21-00622	In vivo reprogramming to rescue alterations in Huntington’s disease	Josep M. Canals	Universitat de Barcelona - Fundació Bosch i Gimpera	Lund University - Cardiff University - Institute of Molecular Biotechnology (IMBA)- European Huntington's Disease Network	Neuroscience	Research Consortium	994.890
HR21-00259	From GFAP mutations in astrocytes to neurodegeneration: exploring a lipid-protein oxidation pathway	Dolores Pérez-Sala	Consejo Superior de Investigaciones Científicas (CSIC)	Brain Center, University Medical Center Utrecht -University of Copenhagen - University of Gothenburg -Institut De Recerca Biomedica De Lleida. Fundació Dr. Pifarre	Neuroscience	Research Consortium	1.000.000
HR21-00824	A strategy to guide and promote spinal and visual axons regeneration after injury	Eloísa Herrera	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Neuroscience	Individual	495.500
HR21-01136	Deep learning of a hippocampal memory code in health and disease	Liset Menéndez de la Prida	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Neuroscience	Individual	491.700
HR21-01208	RBM10, a novel splicing regulator and tumor suppressor: from mechanisms to therapies	Juan Valcárcel	Centre de Regulació Genòmica (CRG)	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	Oncology	Research Consortium	816.239,46
HR21-00176	Understanding lncRNAs in replicative stress and colorectal cancer: from cancer biology to single-molecules	Maite Huarte	Fundación para la Investigación Médica Aplicada (FIMA/CIMA)	Consejo Superior de Investigaciones Científicas (CSIC) - Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	Oncology	Research Consortium	995.200
HR21-00761	IL7R in lung cancer development, metastasis and resistance to immune checkpoint inhibitor therapy	João Barata	Instituto de Medicina Molecular	Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre - Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	Oncology	HR Consortium	999.962
HR21-00083	Interleukin-8 and neutrophil extracelular traps as actionable hurdles for cancer immunotherapy	Ignacio Melero	Fundación para la Investigación Médica Aplicada (FIMA/CIMA)	N/A	Oncology	Individual	498.850
HR21-00020	Cracking the cancer tubulin code for precision oncology	Helder Maiato	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação	N/A	Oncology	Individual	499.983
Projetos premiados em colaboração com a Fundação Luzon
HR21-00931	Targeting TDP-43 with protein kinase inhibitors: a effective and measurable therapy for ALS	Ana Martinez	Consejo Superior de Investigaciones Científicas (CSIC)	FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento -Universidad Complutense de Madrid	Neuroscience	Research Consortium	500.000
Projetos premiados em colaboração com a Fundação para a Ciência e a Tecnologia, I.P. no âmbito da "Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b"
HR21-01212	Decoding the non-code of beta-cells cis-regulation	Jose Bessa	i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação	N/A	Cardiovascular and associated metabolic diseases	Individual	499.355
HR21-00605	Protecting the brain from metastatic breast cancer	Miguel Castanho	Instituto de Medicina Molecular	Asociación Instituto Biodonostia - FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento - Asociación Centro de Investigación Cooperativa en Biomateriales	Enabling Technologies	Research Consortium	632.841
HR21-00533	A flexible platform for generating synthetic virus to control infectious diseases	Joana Azeredo	Universidade do Minho	N/A	Infectious diseases	Individual	492.460,48
HR21-01077	Regulation of prefrontal cortical synaptic function and behavior by chronic stress-induced microRNA-186-5p	Paulo Pinheiro	Centro de Neurociências e Biologia Celular	N/A	Neuroscience	Individual	492.304,48
HR21-00077	Regulatory RNA–protein interactions at telomeres in healthy cells and during malignant transformation	Claus Maria Azzalin	Instituto de Medicina Molecular	N/A	Oncology	Individual	495.792

Projetos selecionados Health Research 2020

CODE	PROJECT TITLE	PROJECT LEADER	HOST INSTITUTION	PARTNER INSTITUTIONS	THEMATIC AREA	CATEGORY	BUDGET (€)
HR20-00493	Function of a novel program of islet microexons in beta cell development, insulin secretion and diabetes	Manuel Irimia	Centre de Regulació Genòmica (CRG)	N/A	Cardiovascular and metabolic diseases	Individual	499.592
HR20-00075	Flow-driven inflammation and arterial wall remodeling in atherosclerosis: mechanisms and therapeutic potential	Miguel Ángel del Pozo	Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC	Yale University, New Haven, CT, Aarhus University, Asociación Centro de Investigación Cooperativa en Biomateriales	Cardiovascular and metabolic diseases	Research Consortium	999.987
HR20-00322	RNA mis-splicing in hypertrophic cardiomyopathy: opportunities for diagnosis and therapy	Maria Carmo-Fonseca	Instituto de Medicina Molecular	Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento, Associação para Investigação e Desenvolvimento da Faculdade de Medicina	Cardiovascular and metabolic diseases	Research Consortium	986.964
HR20-00051	Succinate/SUCNR1 axis: a novel target for anti-obesity therapies	Sonia Fernandez	Fundació Institut d'Investigació Sanitària Pere Virgili	Universidad de Santiago de Compostela, Institut D'Investigació Biomèdica De Girona (IDIBGI)	Cardiovascular and metabolic diseases	Research Consortium	998.902
HR20-00369	Enabling technologies to map nuclear mechanosensing: from organoids to tumors	Xavier Trepat	Institut de Bioenginyeria de Catalunya	Netherlands Cancer Institute	Enabling technologies	Research Consortium	984.630
HR20-00800	Deep Learning to Dissect the Interaction between Leukemic Cells and the Ageing Niche	M. Carolina Florian	Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)	Universität Ulm	Enabling technologies	Research Consortium	817.045
HR20-00637	BioPrinted hydROgel MicrofluIdicS to mimic patient-specific tumor mEtastatic microenvironment	Elena Martinez	Institut de Bioenginyeria de Catalunya	Laboratorio Ibérico Internacional de Nanotecnologia, Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)	Enabling technologies	Research Consortium	981.675
HR20-00428	Heterogenous protein acylation and cancer	Gemma Triola	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Enabling technologies	Individual	341.242
HR20-00218	Enhancing Tissue-Specific Immune Microenvironments for the Cure of HIV	María José Buzón	Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)	Consejo Superior de Investigaciones Científicas (CSIC), Institut de Recerca de la Sida "la Caixa" - IRSICAIXA	Infectious diseases	Research Consortium	699.134
HR20-00361	Mechanism and function of epitranscriptomic poly(A) tail modifications in African trypanosomes	Luisa Figueiredo	Instituto de Medicina Molecular Joao Lobo Antunes	N/A	Infectious diseases	Individual	499.400
HR20-00635	Coping with unpredictability: regulatory plasticity as an adaptation strategy in the human malaria parasite	Elena Gomez-Díaz	Consejo Superior de Investigaciones Científicas (CSIC)	University of Glasgow, University of Sciences, Techniques and Technologies of Bamako (USTTB), Malaria Rsearch and Training Center	Infectious diseases	Research Consortium	999.548
HR20-00584	Discovery of new antiparasitic drug candidates and innovative modes of actions from Microbial Natural Products	Olga Genilloud	Fund. Centro de Excelencia en Inv. de Medicamentos Innovadores en Andalucia	Drugs for Neglected Diseases Initiative (DNDi), Institut Pasteur korea	Infectious diseases	Research Consortium	995.251
HR20-01000	Encoding reward and aversion in the mammalian brain: the overlooked role of endogenous opioids	Ana Joao Rodrigues	Universidade do Minho	N/A	Neuroscience	Individual	499.788
HR20-00083	Restoration of sensory circuits based on glia-to-neuron reprogramming	Guillermina López-Bendito	Consejo Superior de Investigaciones Científicas (CSIC)	N/A	Neuroscience	Individual	499.000
HR20-00081	Amino acid transporter structure to target glutamate transmission in neuro diseases	Manuel Palacin	Fundació Institut de Recerca Biomèdica (IRB Barcelona)	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III	Neuroscience	Research Consortium	428.500
HR20-00896	Mitochondrial transcription as a trigger for neurodegenation	Albert Quintana	Universitat Autònoma de Barcelona (UAB)	N/A	Neuroscience	Individual	500.000
HR20-00714	A cortical pathogenesis of Parkinson's disease	Guglielmo Foffani	Fundación de Investigación HM Hospitales	N/A	Neuroscience	Individual	500.000
HR20-00465	Immunomodulatory drivers in melanoma progression and therapy response	Marisol Soengas	Fund. del Sector Público Estatal Centro Nacional de Inv. Oncológicas Carlos III	N/A	Oncology	Individual	481.597
HR20-00164	A new functional paradigm for RhoA gene mutations in peripherial Tcell Lymphoma: Functional and Clinical implications	Xose R. Bustelo	Fundación de Investigación del Cancer	N/A	Oncology	Individual	498.300
HR20-00871	Gene Regulatory NETworks in NORmal and MALignant Hematopoiesis-Identification and Targeting (GR-NET NORMAL-HIT)	Felipe Prosper	Universidad de Navarra	Fundación para la Investigación Médica Aplicada (FIMA/CIMA), Fundación Miguel Servet - Navarrabiomed, University of Cambridge	Oncology	Research Consortium	999.410
HR20-00411	Virtual patient derived xenografts for tumor treatment	Luciano Di Croce	Centre de Regulació Genòmica (CRG)	Fundació Sant Joan de Déu	Oncology	Research Consortium	990.160
Proyectos galardonados en colaboración con la Fundación Luzón
HR20-01109	Brain Liquid Biopsy for Alzheimer disease and neurodegenerative disorders	Maite Mendioroz	Fundación Miguel Servet - Navarrabiomed	N/A	Neuroscience	Individual	482.847
Proyectos galardonados en colaboración con la Fundação para a Ciência e a Tecnologia, I.P. en el marco de la “Iniciativa Ibérica de Investigaçao e Inovaçao Biomédica, i4b"
HR20-00249	Diamond Photonics Platforms for Synaptic Connectivity Assessment in Healthy and Parkinson Disease Neuronal Models	Jana B. Nieder	Laboratorio Ibérico Internacional de Nanotecnologia	Universidade do Minho, Universidade de Aveiro	Enabling technologies	Research Consortium	999.981
HR20-00841	Unravelling pulmonary neuroimmune circuits during infection	Henrique Veiga-Fernandes	Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud	N/A	Infectious disease	Individual	499.950
HR20-00904	Potassium channel dysfunction in models of neurodevelopmental disorders	Ana Luisa Carvalho	Centro de Neurociências e Biologia Celular	IINS - Interdisciplinary Institute for Neuroscience, CNRS 5297, University of Bordeaux	Neuroscience	Research Consortium	782.000

Projetos selecionados Health Research 2019

CODE	PROJECT TITLE	PROJECT LEADER	HOST INSTITUTION	PARTNER INSTITUTIONS	THEMATIC AREA	TYPE	BUDGET (€)
HR18-00120	Mapping the pathogenesis of vascular malformations	Mariona Graupera	Institut d'Investigació Biomèdica de Bellvitge	Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.), Fundación Privada Hospital de la Santa Creu i Sant Pau, Fundació Sant Joan de Déu	Cardiovascular and metabolic diseases	Research Consortium	755.018
HR18-00068	Nitric Oxide signaling and proteoglycans in Marfan syndrome’s aortopathy: mechanisms and new therapeutic targets	Juan Miguel Redondo Moya	Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)	Consejo Superior de Investigaciones Científicas	Cardiovascular and metabolic diseases	Research Consortium	500.000
HR18-00304	Dysfunction of Ion Channel Complexes in Inheritable Cardiac Diseases	José Jalife	Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)		Cardiovascular and metabolic diseases	Individual	499.895
HR18-00100	Hypothalamic control of gut function and microbiota composition: implications for energy balance regulation	Marc Claret Carles	Institut d'Investigacions Biomèdiques August Pi i Sunyer	Université catholique de Louvain (UCLouvain), Universidad de Santiago de Compostela	Cardiovascular and metabolic diseases	Research Consortium	972.183
HR18-00359	Origin and functions of the tumor stroma in metastatic colorectal cancer	Eduard Batlle	Fundació Institut de Recerca Biomèdica (IRB Barcelona)		Oncology	Individual	499.997
HR18-00069	Next-generation CAR-DOT cells for allogeneic adoptive cancer immunotherapy	Bruno Miguel de Carvalho Silva-Santos	Instituto de Medicina Molecular	Josep Carreras Leukemia Research Institute (JCLRI)	Oncology	Research Consortium	999.997
HR18-00302	Post-transcriptional gene regulation reprogramming in obesity-driven liver cancer	Raúl Méndez	Fundació Institut de Recerca Biomèdica (IRB Barcelona)		Oncology	Individual	499.883
HR18-00256	Defining The Role of Exosome-Secreted Micropeptides in Pancreatic Cancer	Maria Abad	Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)	Fundación Centro Nacional de Investigaciones Oncológicas Carlos III, Champalimaud Foundation	Oncology	Research Consortium	694.600
HR18-00023	Targeting Telomeres in Cancer	Maria A. Blasco	Fundación Centro Nacional de Investigaciones Oncológicas Carlos III		Oncology	Individual	489.100
HR18-00589	Sensitizing pancreatic cancer to immunotherapy with multimodal precision nanomedicines	Maria Jesús Vicent Docón	Centro de Investigación Príncipe Felipe	Facultade de Farmacia da Universidade de Lisboa, Sackler Faculty of Medicine. Tel Aviv University	Enabling technologies	Research Consortium	985.042
HR18-00501	Light-regulated drugs to restore sight	Pau Gorostiza Langa	Institut de Bioenginyeria de Catalunya	Universidad Miguel Hernández de Elche (UMH), Consejo Superior de Investigaciones Científicas, Barcelona Macula Foundation Research (BMF), Universidad de Alcalá (UAH)	Enabling technologies	Research Consortium	498.051
HR18-00336	Community-Driven Big Data Intelligence to Fight Mosquito-Borne Disease	Frederic Bartumeus Ferré	Consejo Superior de Investigaciones Científicas	Universitat Pompeu Fabra, Max Planck Institute for Demographic Research (MPDIR), National Center of Epidemiology (CNE). CIBERESP/ISCIII., Centre for Ecological Research and Forestry Applications (CREAF), Agència de Salut Pública de Barcelona (ASPB),Agencia de Salut Pública de Catalunya (ASPCAT). Generalitat de Catalunya, Centro de Coordinación de Alertas y Emergencias Sanitarias (CCAES)	Enabling technologies	Research Consortium	999.920
HR18-00313	Adaptive Retinal Implant Technology for Vision Restoration	Jose Antonio Garrido Ariza	Fundació Institut Català de Nanociència i Nanotecnologia	Institut de Física d'Altes Energies (IFAE), The Institute of Photonic Sciences (ICFO), Barraquer Foundation (BF), Institut de la Vision (Sorbonne Université)	Enabling technologies	Research Consortium	999.715
HR18-00058	Bacterial lung chassis for treating human lung infectious diseases	Luis Serrano Pubul	Fundació Centre de Regulació Genòmica	Institut d'Investigacions Biomèdiques August Pi i Sunyer	Infectious diseases	Research Consortium	999.528
HR18-00469	Locking cells against Ebola virus	Carmen Gil	Consejo Superior de Investigaciones Científicas	Instituto de Investigación Biomédica Hospital 12 de Octubre (Imas12), Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Bernhard Nocht Institute for Tropical Medicine	Infectious disease	Research Consortium	995.068
HR18-00267	Dissecting the initial molecular events that trigger sexual conversion and transmission in malaria parasites	Alfred Cortés Closas	Barcelona Institute for Global Health (ISGlobal)		Infectious diseases	Individual	499.400
HR18-00104	Enhancing Tissue Resident Immunity	Marc Veldhoen	Instituto de Medicina Molecular		Infectious diseases	Individual	497.158
HR18-00155	Exosome targeting of the hypothalamus: a novel strategy for the treatment of obesity	Miguel Antonio López Pérez	Universidad de Santiago de Compostela		Neuroscience	Individual	448.300
HR18-00026	DUbbing Language-therapy CINEma-based in Aphasia post-Stroke. A feasibility cross-over pilot-trial	Blanca Fuentes Gimeno	Hospital Universitario la Paz	Universidad Pontificia de Comillas, Afasia Activa	Neuroscience	Research Consortium	308.066
HR18-00178	Dyslexia and the thalamus: Integrating anatomy and function in a mechanistic account of the reading brain	Manuel Francisco Carreiras Valiña	Asociacion Basque Center on Cognition, Brain and Language		Neuroscience	Individual	500.000
HR18-00452	Modulation of Tau seeding and pathology in tauopathies by BBB-nanocarriers, epitope selective vaccination and ectoPrP Tau receptor bodies	José Antonio Del Río Fernández	Institut de Bioenginyeria de Catalunya	Institut d'Investigació Biomèdica de Bellvitge, Institute for Research in Biomedicine (IRB Barcelona), Universitat de Barcelona and Institute of Complex Systems (UBICS)	Neuroscience	Research Consortium	763.002
HR18-00007	Dynamics of the neural, metabolomic and neuropsychological signatures underlying the adaptations for motherhood during pregnancy	Oscar Vilarroya Oliver	Universitat Autònoma de Barcelona	Fundació Institut Mar d'Investigacions Mèdiques, Instituto de Investigación Sanitaria Gregorio Marañón , University of Lleida-IRBLleida, Reproductive Medicine Service at Dexeus Women Health	Neuroscience	Research Consortium	972.414
Projetos premiados em colaboração com a Fundação Luzon
HR18-000341	A potential metabolic-targeted therapeutic for Amyotrophic lateral sclerosis (ALS): Leptin	Carmen Maria Fernandez-Martos	Fundación Hospital Nacional de Parapléjicos	San Pablo University, King´s College London and Wicking Dementia Centre/University of Tasmania	Neuroscience	Research Consortium	499979
Projetos premiados em colaboração com a Fundação para a Ciência e a Tecnologia, I.P. no âmbito da "Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b"
HR18-00187	Targeting induced-senescent cells: a novel approach to promote spinal cord regeneration in mammals	Leonor Saúde	Instituto de Medicina Molecular		Neuroscience	Individual	444048
HR18-00502	Metabolic Reprograming In Sepsis	Miguel Che Parreira Soares	Fundação Calouste Gulbenkian	Universitätsklinikum Jena, Center for Sepsis Control and Care, Thüringen (Germany)	Infectious disease	Research Consortium	500000

Projetos selecionados Health Research 2018

CODE	PROJECT TITLE	PROJECT LEADER	HOST INSTITUTION	PARTNER INSTITUTIONS	THEMATIC AREA	CATEGORY	BUDGET (€)
HR17- 00016	Readying immune cells prior to disease-inducing encounters	Francisco Sánchez-Madrid	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	N/A	Infectious disease	A	499.731
HR17- 00040	Understanding muscle regenerative decline with aging	Pura Muñoz-Cánoves	Universitat Pompeu Fabra (UPF)	N/A	Other biomedical areas	A	496.630
HR17- 00092	Metastasis Cell Fate Mapping	Roger Gomis Cabré	Institute for Research in Biomedicine (IRB)	N/A	Oncology	A	489.400
HR17- 00094	Eradicating prostate cancer metastasis before clinical manifestation	Arkaitz Carracedo	CIC bioGUNE	University of Cambridge (UK), Fundação Champalimaud (Lisboa), CIC biomaGUNE, Basurto Hospital	Oncology	A	499.915
HR17- 00149	A Translational Model of Antibody-mediated Synaptic Disease: Symptoms, Neuronal Circuits, and the Mechanisms of Memory Loss and Recovery	Josep Dalmau Obrador	Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	N/A	Neuroscience	A	498.718
HR17- 00199	Towards a universal therapeutic vaccine against chronic virus infections	Andreas Meyerhans	Universitat Pompeu Fabra (UPF)	IrsiCaixa	Infectious disease	A	484.316
HR17- 00221	Genomic and epigenomic drivers of disease evolution in chronic lymphocytic leukemia. Targets for clinical intervention	Elías Campo	Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	Universidad de Oviedo (UNIOVI), Barcelona Supercomputing Center (BSC)	Oncology	B	999.270
HR17- 00231	Regenerating photoreceptors in human retinal organoids to establish a treatment for Retinitis Pigmentosa	Maria Pia Cosma	Fundació Centre de Regulació Genòmica (CRG)	Institute for Bioengineering of Catalonia (IBEC), Instituto Barraquer	Neuroscience	A	499.519
HR17- 00232	Exploiting post-transcriptional regulation to uncover novel vulnerabilities of metastatic cells	Fátima Gebauer Hernández	Fundació Centre de Regulació Genòmica (CRG)	Centro Nacional de Investigaciones Oncológicas (CNIO)	Oncology	A	499.980
HR17- 00247	The antibody immune response during vascular remodeling	Almudena Rodríguez Ramiro	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Fundación Jimenez Diaz	Cardiovascular disease	A	499.963
HR17- 00264	Plasmodium Exploitation of Liver-specific Methionine Metabolism	Maria M. Mota	Instituto de Medicina Molecular (IMM), Lisboa	N/A	Infectious disease	A	499.950
HR17- 00267	Somatic Mutation-driven Clonal Hematopoiesis in Atherosclerosis - International Consortium	Valentí Fuster	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	University of Virginia (UVA)	Cardiovascular disease	B	999.896
HR17- 00268	Therapeutic targeting of MBNL microRNAs as innovative treatments for myotonic dystrophy	Ruben Artero-Allepuz	Universitat de Valencia	University of Oxford (UK), Institute for Bioengineering of Catalonia (IBEC), Institut IMAGINE (France), Institute Biodonostia, ASEM & Myotonic Dystrophy Foundation	Other biomedical areas	B	997.024
HR17- 00323	Optical dissection of cortical circuits for sensory expectations	Leopoldo Petreanu	Fundação Champalimaud, Lisboa	N/A	Neuroscience	A	499.708
HR17- 00409	Fighting Zika virus with antiviral peptides and conjugates translocating blood-placental and blood-brain barriers	David Andreu Martínez	Universitat Pompeu Fabra (UPF)	Instituto de Medicina Molecular (IMM), Instituto de Bioquímica Médica Leopoldo de Meis	Infectious disease	B	777.250
HR17- 00513	Modulation of age-dependent neuromelanin accumulation as a novel therapeutic strategy for Parkinson’s disease and brain aging	Miquel Vila Bover	Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)	N/A	Neuroscience	A	466.004
HR17- 00527	Therapeutic targeting of the neutrophil clock in cardiovascular disease	Andrés Hidalgo Alonso	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Universidad Complutense de Madrid (UCM), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)	Cardiovascular disease	A	499.998
HR17- 00539	Identifying and testing the metabolites generated by two psychoactive gut bacteria to alter brain function and behavior	Carlos Vidal Ribeiro	Fundação Champalimaud, Lisboa	N/A	Neuroscience	A	463.694
HR17- 00595	Organismal role of the ER membrane complex: a conserved machinery required for membrane protein biogenesis.	Colin Adrain	Calouste Gulbenkian Foundation, Lisboa	Institute of Chemical and Biological Technology (ITQB-NOVA, Lisboa), Institute of Organic Chemistry and Biochemistry of the CAS (Czech Republic)	Other biomedical areas	B	960.769
HR17- 00627	Dissecting the functional role of the epicardium metabolism during heart development and repair after myocardial infarction	Ofelia María Martínez Estrada	Fundació Bosch i Gimpera (UB)	Fundació Hospital Universitari Vall d'Hebron Institut de Recerca (VHIR), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP)	Cardiovascular disease	A	438.100
Projetos premiados em colaboração com a Fundação Luzon
HR17- 00777	Activation of the resolution programs of inflammation as a novel therapeutic approach for the treatment of amyotrophic lateral sclerosis	Rubèn López Vales	Universitat Autònoma de Barcelona (UAB)	N/A	Neuroscience	A	500000
Projetos premiados em colaboração com a Fundação para a Ciência e a Tecnologia, I.P. no âmbito da "Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b"
HR17- 00523	Adenosine A2A receptors as a new opportunity to manage and detail the neurobiology of emotional distress	Rodrigo A. Cunha	Centro de Neurociências e Biologia Celular (CNC), Coimbra	N/A	Neuroscience	A	333516
HR17- 00634	A Transdisciplinary Approach to the Identification of Personalized Biomarkers and Therapeutic Targets for Chronic Pulmonary Aspergillosis	Agostinho Albérico Rodrigues de Carvalho	Universidade do Minho	Fundación Universitaria San Pablo (CEU), Foundation for Research and Technology-Hellas, Jena University Hospital and Radboudumc	Infectious disease	B	999027
HR17- 00601	Exosomal fat-liver axis in nonalcoholic fatty liver disease: function and targeting	Rui Eduardo Mota Castro	Universidade de Lisboa	Instituto Biodonostia, École polytechnique fédérale de Lausanne (EPFL) and CIC bioGUNE	Other biomedical areas	A	500000
HR17- 00636	Sequential Cardiac Resynchronization Therapy	Joaquim Adelino Correia Ferreira Leite Moreira	Universidade do Porto	N/A	Cardiovascular disease	A	369248